saltea Mare Plânge bcl 2 marker in colorectal cases Abil Intenționează
Expression of Bcl-2 protein is decreased in colorectal adenocarcinomas with microsatellite instability | Oncogene
Frontiers | Targeting the Bcl-2 Family in B Cell Lymphoma
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival | Cell Death & Disease
Frontiers | Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer | Gut
Cancers | Free Full-Text | BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas
Phosphorylation of Bcl-2 plays an important role in glycochenodeoxycholate-induced survival and chemoresistance in HCC
Frontiers | The Multifaceted Roles of the BCL-2 Family Member BOK
Bcl-2 is a critical mediator of intestinal transformation | Nature Communications
BCL-XL inhibition induces an FGFR4-mediated rescue response in colorectal cancer - ScienceDirect
Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer | Nature Communications
Localization of Bcl-3 in normal colon tissue and in colon cancer. Bcl-3... | Download Scientific Diagram
A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy | Cell Death & Disease
Cancers | Free Full-Text | Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance in Cancer | HTML
Medicina | Free Full-Text | The Expression Pattern of Bcl-2 and Bax in the Tumor and Stromal Cells in Colorectal Carcinoma | HTML
Frontiers | The role of BCL-2 family proteins in regulating apoptosis and cancer therapy
Targeting BCL-2 regulated apoptosis in cancer | Open Biology
BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer | Cell Death & Differentiation
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin | PLOS ONE
Bcl-xL is an oncogenic driver in colorectal cancer | Cell Death & Disease
The BCL-2 protein family, BH3-mimetics and cancer therapy | Cell Death & Differentiation
Cancers | Free Full-Text | Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives
Apoptosis evasion via long non-coding RNAs in colorectal cancer | Cancer Cell International | Full Text
Cancers | Free Full-Text | Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models | HTML
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy | SpringerLink
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy | SpringerLink
Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment - ScienceDirect